Multiomics Identification of Potential Targets for Alzheimer Disease and Antrocin as a Therapeutic Candidate
Sign Up to like & getrecommendations! Published in 2021 at "Pharmaceutics"
DOI: 10.3390/pharmaceutics13101555
Abstract: Alzheimer’s disease (AD) is the most frequent cause of neurodegenerative dementia and affects nearly 50 million people worldwide. Early stage diagnosis of AD is challenging, and there is presently no effective treatment for AD. The… read more here.
Keywords: alzheimer disease; multiomics identification; disease; potential targets ... See more keywords